Table 3.
Models | Variables | Coefficient | 95% CI | P-value | |
---|---|---|---|---|---|
Model 1. Intervention period (week 4–16) |
Intercept | 2.013 | 0.810 | 3.216 | 0.001 |
log plasma HIV RNA at week 4 | 0.672 | 0.385 | 0.959 | <0.001 | |
Ingestible sensor (ref: UC) | 0.851 | −0.912 | 2.614 | 0.341 | |
Average adherence at weeks 4, 8, 12,16 | −1.512 | −2.740 | −0.284 | 0.016 | |
IS∗Adherence | −0.882 | −2.847 | 1.082 | 0.375 | |
Model 2. Post-intervention period (week 16–28) |
Intercept | 2.964 | 1.418 | 4.510 | <0.001 |
Log plasma HIV RNA at week 16 | 0.532 | 0.256 | 0.807 | <0.001 | |
Ingestible sensor (ref: UC) | −0.734 | −3.180 | 1.713 | 0.553 | |
Average adherence at weeks 16, 20, 24, 28 | −2.073 | −3.587 | −0.560 | 0.008 | |
IS∗Adherence | 0.670 | −2.013 | 3.352 | 0.621 | |
Model 3. Longitudinal mixed-effects (week 4–28) |
Intercept | 1.722 | 1.231 | 2.219 | <0.001 |
Week | −0.003 | −0.030 | 0.023 | 0.799 | |
Week2 | 0.0003 | −0.001 | 0.001 | 0.454 | |
Ingestible sensor (ref: UC) | −0.726 | −1.365 | −0.081 | 0.028 | |
Weekly adherence | −0.423 | −0.900 | 0.048 | 0.082 | |
IS∗Adherence | 0.723 | 0.024 | 1.413 | 0.042 | |
Baseline log plasma HIV RNA | 0.274 | 0.188 | 0.360 | <0.001 |
IS, ingestible sensor; UC, usual care.